Literature DB >> 16906587

ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutations.

Antonella Zucchetto1, Riccardo Bomben, Michele Dal Bo, Paola Nanni, Pietro Bulian, Francesca Maria Rossi, Maria Ilaria Del Principe, Simone Santini, Giovanni Del Poeta, Massimo Degan, Valter Gattei.   

Abstract

BACKGROUND: Expression of T cell specific zeta-associated protein 70 (ZAP-70) by B-cell chronic lymphocytic leukemia (B-CLL) cells, as investigated by flow cytometry, has both prognostic relevance and predictive power as surrogate for immunoglobulin heavy chain variable region (IgV(H)) mutations, although a standardization of the cytometric protocol is still lacking.
METHODS: Flow cytometric analyses for ZAP-70 were performed in peripheral blood samples from 145 B-CLL (124 with IgV(H) mutations) by a standard three-color protocol. Identification of ZAP-70(+) cell population was based on an external negative control, i.e., the isotypic control (ISO method) or an internal positive control, i.e., the population of residual normal T/NK cells (TNK method). A comparison between these two approaches was performed.
RESULTS: While 86/145 cases were concordant as for ZAP-70 expression according to the two methods (ISO(+)TNK(+) or ISO(-)TNK(-)), 59/145 cases had discordant ZAP-70 expression, mainly (56/59) showing a ISO(+)TNK(-) profile. These latter cases express higher levels of ZAP-70 in their normal T cell component. Moreover, discordant ISO(+)TNK(-) cases had a IgV(H) gene mutation profile similar to that of concordantly positive cases and different from ZAP-70 concordantly negative B-CLL.
CONCLUSION: Analysis of ZAP-70 expression by B-CLL cells by using the ISO method allows to overcome the variability in the expression of ZAP-70 by residual T cells and yields a better correlation with IgV(H) gene mutations. A receiver operating characteristic analysis suggests to employ a higher cut-off than the commonly used 20%. A parallel evaluation of the prognostic value of ZAP-70 expression, as determined according to the ISO and TNK methods, is still needed. (c) 2006 International Society for Analytical Cytology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16906587     DOI: 10.1002/cyto.b.20127

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  7 in total

Review 1.  Detection methods of ZAP-70 in chronic lymphocytic leukemia.

Authors:  Yin-Hua Wang; Lei Fan; Wei Xu; Jian-Yong Li
Journal:  Clin Exp Med       Date:  2011-06-21       Impact factor: 3.984

2.  CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study.

Authors:  Giovanni Del Poeta; Maria Ilaria Del Principe; Antonella Zucchetto; Fabrizio Luciano; Francesco Buccisano; Francesca Maria Rossi; Antonio Bruno; Annalisa Biagi; Pietro Bulian; Luca Maurillo; Benedetta Neri; Riccardo Bomben; Cristina Simotti; Angela Maria Coletta; Michele Dal Bo; Paolo de Fabritiis; Adriano Venditti; Valter Gattei; Sergio Amadori
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

3.  Methodological comparison of two anti-ZAP-70 antibodies.

Authors:  Heba A Degheidy; David J Venzon; Mohammed Z H Farooqui; Fatima Abbasi; Diane C Arthur; Wyndham H Wilson; Adrian Wiestner; M A Stetler-Stevenson; Gerald E Marti
Journal:  Cytometry B Clin Cytom       Date:  2011-04-06       Impact factor: 3.058

4.  Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells.

Authors:  Francesca M Rossi; Maria Ilaria Del Principe; Davide Rossi; Maria Irno Consalvo; Fabrizio Luciano; Antonella Zucchetto; Pietro Bulian; Riccardo Bomben; Michele Dal Bo; Marco Fangazio; Dania Benedetti; Massimo Degan; Gianluca Gaidano; Giovanni Del Poeta; Valter Gattei
Journal:  J Transl Med       Date:  2010-03-08       Impact factor: 5.531

5.  IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.

Authors:  Pietro Bulian; Davide Rossi; Francesco Forconi; Giovanni Del Poeta; Francesco Bertoni; Emanuele Zucca; Marco Montillo; Gabriele Pozzato; Giovanni D'Arena; Dimitar G Efremov; Roberto Marasca; Francesco Lauria; Gianluca Gaidano; Valter Gattei; Luca Laurenti
Journal:  J Transl Med       Date:  2012-01-30       Impact factor: 5.531

Review 6.  Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance.

Authors:  Michele Dal-Bo; Francesco Bertoni; Francesco Forconi; Antonella Zucchetto; Riccardo Bomben; Roberto Marasca; Silvia Deaglio; Luca Laurenti; Dimitar G Efremov; Gianluca Gaidano; Giovanni Del Poeta; Valter Gattei
Journal:  J Transl Med       Date:  2009-08-28       Impact factor: 5.531

7.  Using the geometric mean fluorescence intensity index method to measure ZAP-70 expression in patients with chronic lymphocytic leukemia.

Authors:  Yu-Jie Wu; Hui Wang; Jian-Hua Liang; Yi Miao; Lu Liu; Hai-Rong Qiu; Chun Qiao; Rong Wang; Jian-Yong Li
Journal:  Onco Targets Ther       Date:  2016-02-18       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.